# Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

> **NCT06839209** · NA · RECRUITING · sponsor: **ABResearch S.r.l.** · enrollment: 18 (estimated)

## Conditions studied

- Clostridium; Difficile, As Cause of Disease Classified Elsewhere
- Clostridium Difficile Diarrhea

## Interventions

- **DEVICE:** Toxclean 1g

## Key facts

- **NCT ID:** NCT06839209
- **Lead sponsor:** ABResearch S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-27
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839209, "Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06839209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*